NINGBO INNO PHARMCHEM CO.,LTD. recognizes that the efficacy of pharmaceutical products hinges on the quality of their constituent components. Methyl 4-acetamido-5-chloro-2-methoxybenzoate (CAS 4093-31-6) is a prime example of a chemical intermediate where purity and well-defined properties are non-negotiable. This compound serves as a fundamental building block, most notably in the synthesis of Metoclopramide hydrochloride, and understanding its specifications is key for any successful synthesis.

The chemical name, Methyl 4-acetamido-5-chloro-2-methoxybenzoate, and its CAS number, 4093-31-6, are the starting points for identifying this crucial intermediate. Producers often specify an assay of ≥98.0%, indicating a high level of purity. However, the significance of methyl 4-acetamido-5-chloro-2-methoxybenzoate applications extends beyond just the assay. Physical characteristics like its 'White powder' appearance and a defined melting point range (typically 153-156 °C) are critical for consistent processing and reaction kinetics. These details are vital for methyl 4-acetamido-5-chloro-2-methoxybenzoate manufacturers to adhere to, ensuring batch uniformity.

For pharmaceutical buyers, sourcing this chemical intermediate involves a careful evaluation of these properties. The stability of the compound under normal temperatures and pressures, as often cited by methyl 4-acetamido-5-chloro-2-methoxybenzoate suppliers, ensures its integrity during storage and transport. When you need to buy methyl 4-acetamido-5-chloro-2-methoxybenzoate, looking for manufacturers that provide comprehensive technical data will greatly assist in validating its suitability for your specific requirements, particularly for complex pharmaceutical synthesis.

In summary, the successful application of Methyl 4-acetamido-5-chloro-2-methoxybenzoate in producing pharmaceuticals like Metoclopramide hydrochloride is contingent upon its quality. NINGBO INNO PHARMCHEM CO.,LTD. champions the cause of quality assurance in the chemical supply chain, emphasizing that each intermediate, including this key benzoate derivative, must meet exacting standards. By focusing on these critical aspects of purity and properties, the pharmaceutical industry can continue to innovate and deliver safe, effective treatments.